The p110γ isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites

被引:41
|
作者
Thomas, Molly S. [1 ]
Mitchell, Jason S. [1 ]
DeNucci, Christopher C. [1 ]
Martin, Amanda L. [1 ]
Shimizu, Yoji [1 ]
机构
[1] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol,Canc Ctr, Minneapolis, MN 55455 USA
关键词
inflammation; chemokines; leukocyte; activation; trafficking;
D O I
10.1189/jlb.0807561
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of PI-3K in leukocyte function has been studied extensively. However, the specific role of the p110 gamma isoform of PI-3K in CD4 T lymphocyte function has yet to be defined explicitly. In this study, we report that although p110 gamma does not regulate antigen- dependent CD4 T cell activation and proliferation, it plays a crucial role in regulating CD4 effector T cell migration. Nai r ve p110 gamma(-/-) CD4 lymphocytes are phenotypically identical to their wildtype ( WT) counterparts and do not exhibit any defects in TCR- mediated calcium mobilization or Erk activation. In addition, p110 gamma- deficient CD4 OT. II T cells become activated and proliferate comparably with WT cells in response to antigen in vivo. Interestingly, however, antigen- experienced, p110 gamma- deficient CD4 OT. II lymphocytes exhibit dramatic defects in their ability to traffic to peripheral inflammatory sites in vivo. Although antigen- activated, p110 gamma-deficient CD4 T cells express P- selectin ligand, beta 2 integrin, beta 1 integrin, CCR4, CXCR5, and CCR7 comparably with WT cells, they exhibit impaired Factin polarization and migration in response to stimulation ex vivo with the CCR4 ligand CCL22. These findings suggest that p110 gamma regulates the migration of antigen- experienced effector CD4 T lymphocytes into inflammatory sites during adaptive immune responses in vivo.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 50 条
  • [41] Cutting edge:: The phosphoinositide 3-kinase p110δ is critical for the function of CD4+CD25+Foxp3+ regulatory T cells
    Patton, Daniel T.
    Garden, Oliver A.
    Pearce, Wayne P.
    Clough, Louise E.
    Monk, Clare R.
    Leung, Eva
    Rowan, Wendy C.
    Sancho, Sara
    Walker, Lucy S. K.
    Vanhaesebroeck, Bart
    Okkenhaug, Klaus
    JOURNAL OF IMMUNOLOGY, 2006, 177 (10): : 6598 - 6602
  • [42] Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α
    Echeverria, Ignacia
    Liu, Yunlong
    Gabelli, Sandra B.
    Amzel, L. Mario
    FEBS JOURNAL, 2015, 282 (18) : 3528 - 3542
  • [43] The p110α and p110β Isoforms of Class I Phosphatidylinositol 3-Kinase Are Involved in Toll-Like Receptor 5 Signaling in Epithelial Cells
    Ivison, Sabine M.
    Khan, Mohammed A. S.
    Graham, Nicholas R.
    Shobab, Leila A.
    Yao, Yu
    Kifayet, Arnawaz
    Sly, Laura M.
    Steiner, Theodore S.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [44] Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naive Versus Effector CD8+ T Cell Transcriptional Programs
    Spinelli, Laura
    Marchingo, Julia M.
    Nomura, Aneela
    Damasio, Marcos P.
    Cantrell, Doreen A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] The Phosphatidylinositol 3-Kinase p110α/PTEN Signaling Pathway Is Crucial for HIV-1 Entry
    Hamada, Koichi
    Maeda, Yosuke
    Mizutani, Akihiro
    Okada, Seiji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (01) : 130 - 138
  • [46] Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation
    Renner, Oliver
    Blanco-Aparicio, Carmen
    Grassow, Maja
    Canamero, Marta
    Leal, Juan F. M.
    Carnero, Amancio
    CANCER RESEARCH, 2008, 68 (23) : 9643 - 9653
  • [47] Pharmacological Inhibition Of The Pi 3-Kinase Isoform P110α Prevents Vascular Remodeling And Experimental Ph
    Berghausen, E. M.
    Janssen, W.
    Vantler, M.
    Ten Freyhaus, H.
    Baldus, S.
    Schermuly, R.
    Rosenkranz, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] Specific Roles of the p110α Isoform of Phosphatidylinsositol 3-Kinase in Hepatic Insulin Signaling and Metabolic Regulation
    Sopasakis, Victoria Rotter
    Liu, Pixu
    Suzuki, Ryo
    Kondo, Tatsuya
    Winnay, Jonathon
    Tran, Thien T.
    Asano, Tomoichiro
    Smyth, Graham
    Sajan, Mini P.
    Farese, Robert V.
    Kahn, C. Ronald
    Zhao, Jean J.
    CELL METABOLISM, 2010, 11 (03) : 220 - 230
  • [49] Unique Role of the p110α Isoform of PI 3-Kinase in the Regulation of Mitochondrial Homeostasis and Muscle Metabolomics
    Li, Mengyao Ella
    Lauritzen, Hans P. M. M.
    O'Neill, Brian T.
    Cai, Weikang
    Sakaguchi, Masaji
    Kurland, Irwin J.
    Kahn, C. Ronald
    DIABETES, 2017, 66 : LB80 - LB80
  • [50] Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
    Zhao, Li
    Vogt, Peter K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) : 2652 - 2657